3681 — Sinomab Bioscience Share News
0.000.00%
Last trade - 00:00- HK$1.46bn
- HK$1.53bn
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience
Brief: Sinomab Bioscience Posts Loss For Year Rmb105.0 Million
Brief: SinoMab BioScience Announces Termination Of Lease Agreement Between Unit, Haikou Pharmaceutical Factory
Brief: Sinomab Bioscience Says Investigational New Drug Application Approval For IBD Of SM17 By NMPA
Brief: Sinomab Bioscience Says IND Application For SM17 Accepted By NMPA CDE
Brief: Sinomab Bioscience To Issue Aggregate Of 182.1 MLN New Shares At HK$2.03 Per Subscription Share
Brief: SinoMab Bioscience Withdraws Biologics License Application
Brief: Sinomab Bioscience Says Shanchun Wang Resigns As Executive Director
Brief: Sinomab Bioscience Says Shanchun Wang Ceases To Act As President (PRC) Of Group
Brief: Sinomab Bioscience Says Co To Issue 112.8 Million Subscription Shares
Brief: Sinomab Bioscience Posts HY Loss RMB90.6 Million
Brief: Sinomab Bioscience Announces Loss For Year Of RMB243.1 Mln
Brief: Sinomab Bioscience Says Shanchun Wang Appointed As Executive Director
Brief: Sinomab Bioscience Says Co Conditionally Agreed To Issue 56.8 Mln Subscription Shares
Brief: Sinomab Bioscience Gets Ind Application For Sm03 (Suciraslimab) For Treatment Of Alzheimer
Brief: Sinomab Bioscience Receives Ind Approval For SM17 By NMPA